644
Participants
Start Date
January 31, 2011
Primary Completion Date
October 31, 2012
Study Completion Date
August 31, 2013
Fostamatinib and placebo injections
Fostamatinib 100mg twice daily and placebo injection once every two weeks
Fostamatinib and placebo injections
Fostamatinib 100mg twice daily / fostamatinib 150mg once daily and placebo injection once every two weeks
Fostamatinib and placebo injections
Fostamatinib 100mg twice daily / fostamatinib 100mg once daily and placebo injection once every two weeks.
Adalimumab and placebo of fostamatinib
Adalimumab 40mg injection once every two weeks and placebo to fostamatinib twice daily.
Placebo of fostamatinib, fostamatinib, and placebo injections
Placebo injection once every two weeks. Placebo to fostamatinib for six weeks, followed by fostamatinib 100mg twice daily (Group F) / fostamatinib 100mg twice daily then 150mg once daily (Group G).
Research Site, Birmingham
Research Site, Glendale
Research Site, Mesa
Research Site, Phoenix
Research Site, Scottsdale
Research Site, Huntington Beach
Research Site, Long Beach
Research Site, Colorado Springs
Research Site, Bridgeport
Research Site, Daytona Beach
Research Site, Jacksonville
Research Site, Miami
Research Site, Ocala
Research Site, Palm Harbor
Research Site, Pinellas Park
Research Site, Venice
Research Site, Chicago
Research Site, South Bend
Research Site, Bowling Green
Research Site, Elizabethtown
Research Site, Oxon Hill
Research Site, Kalamazoo
Research Site, Richmond Heights
Research Site, Kalispell
Research Site, Nashua
Research Site, Albuquerque
Research Site, Las Cruces
Research Site, Brooklyn
Research Site, Charlotte
Research Site, Perrysburg
Research Site, Duncansville
Research Site, Greenville
Research Site, Jackson
Research Site, Knoxville
Research Site, Memphis
Research Site, Austin
Research Site, Houston
Research Site, Mesquite
Research Site, Plano
Research Site, San Antonio
Research Site, Pleven
Research Site, Plovdiv
Research Site, Rousse
Research Site, Sevlievo
Research Site, Sofia
Research Site, Veliko Tarnovo
Research Site, Mississauga
Research Site, Brno
Research Site, Bruntál
Research Site, Hlučín
Research Site, Liberec
Research Site, Ostrava
Research Site, Ostrava - Poruba
Research Site, Ostrava - Trebovice
Research Site, Prague
Research Site, Zlín
Research Site, Dresden
Research Site, Hamburg
Research Site, München
Research Site, Balatonfüred
Research Site, Budapest
Research Site, Debrecen
Research Site, Zalaegerszeg
Research Site, Amsterdam
Research Site, Bytom
Research Site, Chełm Śląski
Research Site, Grodzisk Mazowiecki
Research Site, Lodz
Research Site, Środa Wielkopolska
Research Site, Warsaw
Research Site, Wroclaw
Research Site, Żyrardów
Research Site, Moscow
Research Site, Nizhny Novgorod
Research Site, Petrozavodsk
Research Site, Ryazan
Research Site, Saint Petersburg
Research Site, Voronezh
Research Site, Yaroslavl
Research Site, Trebišov
Research Site, Trnava
Research Site, Pretoria
Research Site, Durban
Research Site, Cape Town
Research Site, Cape Town
Research Site, Durban
Research Site, Pretoria
Research Site, Stellenbosch
Research Site, Donetsk
Research Site, Ivano-Frankivsk
Research Site, Kharkiv
Research Site, Kyiv
Research Site, Lutsk
Research Site, Lviv
Research Site, Odesa
Research Site, Simferopol
Research Site, Zaporyzhzhya
Research Site, Reading
Research Site, London
Research Site, Eastbourne
Research Site, Basingstoke
Research Site, Eastbourne
Research Site, London
Research Site, Manchester
Research Site, Wolverhampton
Lead Sponsor
AstraZeneca
INDUSTRY